Annual Drug Patent Expirations for EVOCLIN Evoclin is a drug marketed by Mylan and is included in one NDA. There are two patents protecting this drug and one Paragraph IV…
The post New patent expiration for MYLAN drug EVOCLIN appeared first on DrugPate…
This chart shows the pharmaceutical companies with patents in the most countries. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the greatest glo…
Which pharmaceutical companies have the greatest global patent coverage? Read Post »
A recent article published in Health Affairs, delves into the Federal Trade Commission’s (FTC) concerns regarding the inclusion of improper patents in the FDA’s Orange Book by pharmaceutical manufacturers. The…
The post Legislative Proposals to Tackle …
Legislative Proposals to Tackle Improper Pharmaceutical Patents in the Orange Book Read Post »
Annual Drug Patent Expirations for RHOFADE Rhofade is a drug marketed by Mayne Pharma and is included in one NDA. It is available from one supplier. There are eight patents…
The post New patent expiration for Mayne Pharma drug RHOFADE appeared first on…
New patent expiration for Mayne Pharma drug RHOFADE Read Post »
This chart shows the companies which have received the most New Patient Population exclusivities in the past five years. New Patient Populations are one of the categories for which the…
The post Pharmaceutical companies with the most ‘New Patient Popul…
Pharmaceutical companies with the most ‘New Patient Population’ drugs Read Post »
This chart shows the drugs with the most patents in Russian Federation. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical drugs have the most drug patents in Russi…
Which pharmaceutical drugs have the most drug patents in Russian Federation? Read Post »
Annual Drug Patent Expirations for ZAVZPRET Zavzpret is a drug marketed by Pfizer and is included in one NDA. It is available from two suppliers. There are three patents protecting…
The post New patent expiration for Pfizer drug ZAVZPRET appeared first…
Annual Drug Patent Expirations for RYZUMVI Ryzumvi is a drug marketed by Ocuphire and is included in one NDA. The generic ingredient in RYZUMVI is phentolamine mesylate. Additional details are…
The post New patent for Ocuphire drug RYZUMVI appeared fir…
Annual Drug Patent Expirations for VIMOVO Vimovo is a drug marketed by Horizon and is included in one NDA. It is available from two suppliers. There are three patents protecting…
The post New patent for Horizon drug VIMOVO appeared first on DrugPatentW…
Annual Drug Patent Expirations for HALAVEN Halaven is a drug marketed by Eisai Inc and is included in one NDA. It is available from two suppliers. There are two patents…
The post New patent expiration for Eisai Inc drug HALAVEN appeared first on DrugPa…
New patent expiration for Eisai Inc drug HALAVEN Read Post »
Get new actionable insights and updates from BiotechBlog
